Intercept Pharmaceuticals Inc. (ICPT) announced after the close Tuesday that it priced an underwritten public offering of 1,730,000 shares of its common stock at a price of $33.01 per share.
Intercept Pharmaceuticals gapped open higher Wednesday and is currently up 3.01 at $36.02, with volume at a 6-month high. The stock has climbed to a 2 1/2 month high.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.